Back to Browse Journals » Vascular Health and Risk Management » Volume 6

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?

Authors Ajoy Kumar, Vibhuti Singh

Published Date July 2010 Volume 2010:6 Pages 665—669

DOI http://dx.doi.org/10.2147/VHRM.S5686

Published 30 July 2010

Ajoy Kumar1, Vibhuti Singh2

1Bayfront Family Medicine Residency, St Petersburg FL, USA; 2University of South Florida College of Medicine and Suncoast Cardiovascular Center, St Petersburg, FL, USA

Abstract: When compared with the general population, the diabetic population is at higher risk of cardiovascular disease (CVD), as predicted by the Framingham Risk Score calculations (10-year risk 20%). For this reason diabetes is considered a “coronary disease equivalent” condition, as classified by the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP) III. Furthermore, patients with diabetes who experience a myocar­dial infarction have a poorer prognosis than non­diabetic patients, which contributes to their overall higher mortality. Dyslipidemia is a major underlying risk factor contributing to the excess CVD risk, and is usually more atherogenic in the presence of diabetes. It is uniquely manifested by raised levels of triglycer­ides, low levels of high-density lipoprotein cholesterol, and smaller, denser, and more atherogenic low-density lipoprotein particles. Recent trials have suggested the need for more aggressive treatment of dyslipidemia in this subpopulation than the current recommendations by the NCEP-ATP III. This review addresses the newer developments in the diabetes arena in terms of our current understanding of atherogenic dyslipidemia in diabetes and data from the latest randomized trials addressing its management.

Keywords: atherogenic dyslipidemia, diabetes mellitus

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Association of retinal vessel attenuation with visual function in eyes with retinitis pigmentosa

Nakagawa S, Oishi A, Ogino K, Makiyama Y, Kurimoto M, Yoshimura N

Clinical Ophthalmology 2014, 8:1487-1493

Published Date: 12 August 2014

Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability

Neves AR, Lúcio M, Martins S, Lima JL, Reis S

International Journal of Nanomedicine 2013, 8:177-187

Published Date: 7 January 2013

Astigmatism induced by conventional spherical ablation after PRK and LASIK in myopia with astigmatism < 1.00 D

Christiansen SM, Mifflin MD, Edmonds JN, Simpson RG, Moshirfar M

Clinical Ophthalmology 2012, 6:2109-2117

Published Date: 20 December 2012

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Management of hypoactive sexual desire disorder in women: current and emerging therapies

Rossella E Nappi, Ellis Martini, Erica Terreno, et al

International Journal of Women's Health 2010, 2:167-175

Published Date: 1 July 2010

Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome)

Georgios Kitsos, Christos Gartzios, Ioannis Asproudis, et al

Clinical Ophthalmology 2009, 3:537-542

Published Date: 30 September 2009

Duloxetine for the management of fibromyalgia syndrome

Beth A Scholz, Cara L Hammonds, Chad S Boomershine

Journal of Pain Research 2009, 2:99-108

Published Date: 21 July 2009

High prevalence of gastroesophageal reflux symptoms in patients with both acute and nonacute cough

Yoshihisa Urita, Toshiyasu Watanabe, Hiroki Ota, Motohide Iwata, Yosuke Sasaki, et al

International Journal of General Medicine 2008, 1:59-63

Published Date: 29 October 2008

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes

Marc K Israel, Eva Istvan, Michelle A Baron

Vascular Health and Risk Management 2008, 4:1167-1178

Published Date: 2 September 2008

Absence status associated with focal activity and polydipsia-induced hyponatremia

Hideki Azuma, Tatsuo Akechi, Toshi A Furukawa

Neuropsychiatric Disease and Treatment 2008, 4:495-498

Published Date: 16 April 2008